Sunshine Biopharma signs licence deal for Covid-19 treatment
Sunshine Biopharma has signed an exclusive global licence deal with the University of Arizona for PLpro-based Covid-19 treatment.
Stay updated with breaking news from Gregory Thatcher. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Sunshine Biopharma has signed an exclusive global licence deal with the University of Arizona for PLpro-based Covid-19 treatment.
/PRNewswire/ -- The Coronavirus Global Market has been growing in the past few years and is anticipated to continue to grow in the next several years. In fact,...
EQS-News: Sunshine Biopharma Inc. Chinese Lockdown Effects Ripple Marketwide; A Solution Urgently Needed 08.12.2022 / 15:25 CET/CEST The issuer is solely responsible for the content
EQS-News: Sunshine Biopharma Inc. Chinese Lockdown Effects Ripple Marketwide; A Solution Urgently Needed 08.12.2022 / 15:25 CET/CEST The issuer is solely responsible for the content of this announcement. Read the latest report on Sunshine Biopharma here.Protests have mounted in intensity across ...
Study in cells and mice suggests that the variant APOE4 affects the all-important insulation around nerve cells